Seattle, WA, United States of America

Melinda Davis

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Omeros Corporation. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Melinda Davis. Retrieved from https://idiyas.com/inventor/melinda-davis-fmtd34mc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Melinda Davis - Innovator in MASP-2 Inhibitors

Introduction

Melinda Davis is a prominent inventor based in Seattle, Washington. She has made significant contributions to the field of biochemistry, particularly in the development of MASP-2 inhibitors. Her work has the potential to impact various therapeutic applications.

Latest Patents

Melinda holds one patent related to MASP-2 inhibitors and methods of use. The patent provides compounds with MASP-2 inhibitory activity, along with compositions of such compounds and methods for making and using them. This innovation showcases her expertise in creating solutions for complex biological challenges.

Career Highlights

Melinda is currently associated with Omeros Corporation, where she continues to advance her research and development efforts. Her role at the company allows her to collaborate with other talented professionals in the field.

Collaborations

Some of her notable coworkers include Neil S. Cutshall and Jennifer Lynn Gage. Their collective expertise contributes to the innovative environment at Omeros Corporation.

Conclusion

Melinda Davis is a dedicated inventor whose work on MASP-2 inhibitors exemplifies her commitment to advancing medical science. Her contributions are paving the way for new therapeutic options in the healthcare industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…